MEDIVATION, INC.
DelistedCIK 1011835fmd_0B87ZQB9W0EA92G33VAFHKMW7TManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2009 to Jun 30, 2016, 27 periods
| Line item | FY2009 | FY2010 | FY2011 | FY2012 | FY2013 | FY2014 | FY2015 |
|---|---|---|---|---|---|---|---|
| Research and development | 88 | 72 | 73 | 96 | 119 | 190 | 232 |
| Selling, general and administrative | 29 | 23 | 30 | 112 | 176 | 239 | 297 |
| Total operating expenses | 117 | 95 | 103 | 208 | 295 | 429 | 529 |
| Operating income | (47) | (33) | (43) | (26) | (22) | 282 | 415 |
| Interest expense | – | – | – | 15 | 20 | 22 | 12 |
| Interest and investment income | – | 0 | 0 | 0 | 0 | 0 | – |
| Other non-operating income (expense) | 1 | 0 | (0) | (15) | (20) | (22) | (33) |
| Income before taxes | – | (32) | (43) | (41) | (42) | 260 | 381 |
| Income tax expense | 8 | 2 | (4) | 0 | 0 | (16) | 137 |
| Net income from continuing operations | – | (34) | (39) | (41) | (43) | 276 | 245 |
| Net income | (55) | (34) | (39) | (41) | (43) | 276 | 245 |
| Net income to common shareholders | – | – | – | (41) | (43) | 290 | 248 |